Identification of Prognostic Risk Factors for Transient and Persistent Lymphedema after Multimodal Treatment for Breast Cancer.
- Author:
Myungsoo KIM
1
;
Kyung Hwan SHIN
;
So Youn JUNG
;
Seeyoun LEE
;
Han Sung KANG
;
Eun Sook LEE
;
Seung Hyun CHUNG
;
Yeon Joo KIM
;
Tae Hyun KIM
;
Kwan Ho CHO
Author Information
- Publication Type:Original Article
- Keywords: Breast neoplasms; Transient lymphedema; Persistent lymphedema; Risk factors
- MeSH: Arm; Breast Neoplasms*; Breast*; Combined Modality Therapy*; Drug Therapy; Follow-Up Studies; Humans; Incidence; Lymph Nodes; Lymphedema*; Multivariate Analysis; Risk Factors*
- From:Cancer Research and Treatment 2016;48(4):1330-1337
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: The purpose of this study is to identify risk factors for transient lymphedema (TLE) and persistent lymphedema (PLE) following treatment for breast cancer. MATERIALS AND METHODS: A total of 1,073 patients who underwent curative breast surgery were analyzed. TLE was defined as one episode of arm swelling that had resolved spontaneously by the next follow-up; arm swelling that persisted over two consecutive examinations was considered PLE. RESULTS: At a median follow-up period of 5.1 years, 370 cases of lymphedema were reported, including 120 TLE (11.2%) and 250 PLE (23.3%). Initial grade 1 swelling was observed in 351 patients, of which 120 were limited to TLE (34%), while the other 231 progressed to PLE (66%). All initial swelling observed in TLE patients was classified as grade 1. In multivariate analysis, chemotherapy with taxane and supraclavicular radiation therapy (SCRT) were associated with development of TLE, whereas SCRT, stage III cancer and chemotherapy with taxane were identified as risk factors for PLE (p < 0.05). The estimated incidence of TLE among initial grade 1 patients was calculated using up to three treatment-related risk factors (number of dissected axillary lymph nodes, SCRT, and taxane chemotherapy). The approximate ratios of TLE and PLE based on the number of risk factors were 7:1 (no factor), 1:1 (one factor), 1:2 (two factors), and 1:3 (three factors). CONCLUSION: One-third of initial swelling events were transient, whereas the other two-thirds of patients experienced PLE. Estimation of TLE and PLE based on known treatment factors could facilitate prediction of this life-long complication.
